Profile picture

Doctor Taku Asano

St. Luke's International Hospital, Tokyo (Japan)
Follow
Biography
Education 2001-2006 MD, Hamamatsu Medical University School of Medicine Training and Work Experience 2006-2008 Residency program at St. Luke’s International Hospital, Tokyo, Japan 2008-2016 Department of Cardiology, St. Luke’s International Hospital, Tokyo, Japan 2008-2016 Research Fellow at Amsterdam University Medical Center, Amsterdam, the Netherland. 2018-present Department of Cardiology, St. Luke’s International Hospital, Tokyo, Japan License and Certification National Board of Medicine, Registration Board Certified Membership of the Japanese Society of Internal Medicine Board Certified Membership of the Japanese Society of Cardiology CVIT board-certified cardiovascular interventionist Academic Membership Japanese Association of Cardiovascular Intervention and Therapeutics The Japanese Circulation Society The Japanese Society of Internal Medicine
Logo ESC

Contributor content

Twenty-year trends in clinical outcome of randomized controlled trial for coronary intervention: systematic review and meta-regression analysis of 46 randomized controlled trials
Presentation
Twenty-year trends in clinical outcome of randomized controlled trial for coronary intervention: systematic review and meta-regression analysis of 46 randomized controlled trials
The impact of low diastolic blood pressure on 30-day mortality of patients with acute myocardial infarction
Presentation
The impact of low diastolic blood pressure on 30-day mortality of patients with acute myocardial infarction
Relationship between age and the impact of revascularization on mortality in patients with non-ST-elevation myocardial infarction
Presentation
Relationship between age and the impact of revascularization on mortality in patients with non-ST-elevation myocardial infarction
The assessment of microvascular resistance and conductance three years after the implantation of Absorb bioresorbable vascular scaffold and Xience metallic stent: ABSORB II pressure-velocity substudy
Presentation
The assessment of microvascular resistance and conductance three years after the implantation of Absorb bioresorbable vascular scaffold and Xience metallic stent: ABSORB II pressure-velocity substudy
Angiographic late lumen loss revisited: impact on target lesion revascularization and device thrombosis
Presentation
Angiographic late lumen loss revisited: impact on target lesion revascularization and device thrombosis

ESC 365 is supported by